That same month, the journal Science declared glucagon-like peptide-1 (GLP-1) weight loss drugs its Breakthrough of the Year, beating out commendable contenders such as new malaria and Alzheimers treatments, innovative climate change research on natural carbon pumps and artificial intelligence (AI) in improving weather forecasting
The level of an intracellular antioxidant during development determines the adult phenotype in a bird species: A potential organizer role for glutathione
Expertise and Reputation of Healthcare Provider: The experience and reputation of the healthcare provider administering the injections can influence the price
Evaluating Oral Glutathione Plus Ascorbic Acid, Alpha-lipoic Acid, and Zinc Aspartate as a Skin-lightening Agent: An Indonesian Multicenter, Randomized, Controlled Trial
While weight loss might make people seek out GLP-1s, the drugs are still new and recent studies show that they can have negative side effects: 4 in 5 people feel mild to moderate stomach side effects like nausea, vomiting, and diarrhea